These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9746842)

  • 21. Opioid induced hyperalgesia: clinical implications for the pain practitioner.
    Silverman SM
    Pain Physician; 2009; 12(3):679-84. PubMed ID: 19461836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy.
    Qian J; Brown SD; Carlton SM
    Brain Res; 1996 Apr; 715(1-2):51-62. PubMed ID: 8739622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [NMDA receptor antagonists: a new treatment for neuropathic pain].
    Pud D; Eisenberg E
    Harefuah; 1999 Apr; 136(7):564-7. PubMed ID: 15532603
    [No Abstract]   [Full Text] [Related]  

  • 25. Ketamine in cancer pain: an update.
    Mercadante S
    Palliat Med; 1996 Jul; 10(3):225-30. PubMed ID: 8817593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the NMDA-receptor blocker and stimulator ketamine and glycine in the development of a neuropathic pain syndrome].
    Danilova EI; Grafova VN; Reshetniak VK
    Eksp Klin Farmakol; 1997; 60(4):10-3. PubMed ID: 9376747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
    Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
    Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of NMDA-receptor antagonists in the treatment of chronic pain.
    Hewitt DJ
    Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.
    Kornhuber J; Weller M
    Biol Psychiatry; 1997 Jan; 41(2):135-44. PubMed ID: 9018383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glutamate antagonists for treatment of neuropathic pain].
    Block F; Habermeyer B
    Schmerz; 2003 Aug; 17(4):261-7. PubMed ID: 12923675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMDA receptor antagonists and pain: ketamine.
    Muir WW
    Vet Clin North Am Equine Pract; 2010 Dec; 26(3):565-78. PubMed ID: 21056300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of norketamine enantiomers in rodent models of persistent pain.
    Holtman JR; Crooks PA; Johnson-Hardy JK; Hojomat M; Kleven M; Wala EP
    Pharmacol Biochem Behav; 2008 Oct; 90(4):676-85. PubMed ID: 18586315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMDA receptor antagonists for the treatment of neuropathic pain.
    Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
    Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the use of ketamine in pain management.
    Tawfic QA
    J Opioid Manag; 2013; 9(5):379-88. PubMed ID: 24353050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.
    Danysz W; Parsons CG; Kornhuber J; Schmidt WJ; Quack G
    Neurosci Biobehav Rev; 1997 Jul; 21(4):455-68. PubMed ID: 9195603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical applications of excitatory amino acid antagonists in pain management.
    Wong CS; Cherng CH; Ho ST
    Acta Anaesthesiol Sin; 1995 Dec; 33(4):227-32. PubMed ID: 8705156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
    Wiesenfeld-Hallin Z
    Drugs; 1998 Jan; 55(1):1-4. PubMed ID: 9463786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketamine: an introduction for the pain and palliative medicine physician.
    Okon T
    Pain Physician; 2007 May; 10(3):493-500. PubMed ID: 17525784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical role of NMDA receptor antagonists for the treatment of postoperative pain.
    De Kock MF; Lavand'homme PM
    Best Pract Res Clin Anaesthesiol; 2007 Mar; 21(1):85-98. PubMed ID: 17489221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.